Owens & Minor, Inc. (NYSE:OMI - Get Free Report) major shareholder Coliseum Capital Management, L bought 1,738,511 shares of the firm's stock in a transaction dated Friday, February 28th. The shares were purchased at an average price of $9.39 per share, with a total value of $16,324,618.29. Following the acquisition, the insider now directly owns 9,469,698 shares in the company, valued at approximately $88,920,464.22. This trade represents a 22.49 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.
Coliseum Capital Management, L also recently made the following trade(s):
- On Monday, March 3rd, Coliseum Capital Management, L purchased 354,901 shares of Owens & Minor stock. The stock was bought at an average price of $9.19 per share, with a total value of $3,261,540.19.
Owens & Minor Stock Up 0.3 %
Shares of Owens & Minor stock traded up $0.03 on Friday, hitting $10.00. 1,437,004 shares of the company's stock traded hands, compared to its average volume of 1,711,562. The stock has a market cap of $772.08 million, a P/E ratio of -15.38, a PEG ratio of 0.20 and a beta of 0.61. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The firm's 50-day moving average is $11.20 and its 200 day moving average is $13.03. Owens & Minor, Inc. has a 52-week low of $6.07 and a 52-week high of $28.35.
Owens & Minor (NYSE:OMI - Get Free Report) last released its earnings results on Friday, February 28th. The company reported $0.55 EPS for the quarter, beating the consensus estimate of $0.53 by $0.02. The company had revenue of $2.70 billion during the quarter, compared to analysts' expectations of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The business's revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.69 EPS. Equities analysts anticipate that Owens & Minor, Inc. will post 1.51 earnings per share for the current year.
Owens & Minor announced that its board has initiated a stock buyback plan on Friday, February 28th that permits the company to buyback $100.00 million in outstanding shares. This buyback authorization permits the company to purchase up to 13.6% of its shares through open market purchases. Shares buyback plans are often an indication that the company's management believes its stock is undervalued.
Institutional Investors Weigh In On Owens & Minor
Several institutional investors and hedge funds have recently made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Owens & Minor by 29.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 219,761 shares of the company's stock valued at $2,872,000 after acquiring an additional 50,184 shares in the last quarter. Voloridge Investment Management LLC increased its position in Owens & Minor by 24.2% in the fourth quarter. Voloridge Investment Management LLC now owns 243,525 shares of the company's stock worth $3,183,000 after buying an additional 47,459 shares during the period. Squarepoint Ops LLC acquired a new stake in Owens & Minor in the fourth quarter worth $381,000. State of Wyoming increased its position in Owens & Minor by 35.3% in the fourth quarter. State of Wyoming now owns 23,198 shares of the company's stock worth $303,000 after buying an additional 6,050 shares during the period. Finally, ProShare Advisors LLC increased its position in Owens & Minor by 44.5% in the fourth quarter. ProShare Advisors LLC now owns 22,702 shares of the company's stock worth $297,000 after buying an additional 6,996 shares during the period. 98.04% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research firms have weighed in on OMI. UBS Group decreased their price target on Owens & Minor from $25.00 to $13.00 and set a "buy" rating for the company in a report on Thursday, February 13th. Robert W. Baird upped their price target on Owens & Minor from $10.00 to $11.00 and gave the stock a "neutral" rating in a report on Monday, March 3rd. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $15.08.
Check Out Our Latest Report on OMI
About Owens & Minor
(
Get Free Report)
Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.
Further Reading
Before you consider Owens & Minor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.
While Owens & Minor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
